Literature DB >> 18303497

Current methods of prenatal screening for Down syndrome and other fetal abnormalities.

Devereux N Saller1, Jacob A Canick.   

Abstract

Prenatal diagnosis of Down syndrome is widely available, but the determination of which patients should undergo prenatal diagnosis is changing. With the recent acceptance of first-trimester and integrated screening as a part of routine clinical practice, there are now a variety of accepted screening protocols for Down syndrome and other aneuploidies. These choices can be confusing both to both patients and providers. The following discussion is meant to outline the various options in prenatal screening, and their individual advantages and disadvantages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303497     DOI: 10.1097/GRF.0b013e318160f274

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  5 in total

1.  Information and decision support needs of parents considering amniocentesis: interviews with pregnant women and health professionals.

Authors:  Marie-Anne Durand; Mareike Stiel; Jacky Boivin; Glyn Elwyn
Journal:  Health Expect       Date:  2010-06       Impact factor: 3.377

2.  Parental-age effects in Down syndrome.

Authors:  Santhosh Girirajan
Journal:  J Genet       Date:  2009-04       Impact factor: 1.166

3.  Non-invasive prenatal testing: ethical issues explored.

Authors:  Antina de Jong; Wybo J Dondorp; Christine E M de Die-Smulders; Suzanne G M Frints; Guido M W R de Wert
Journal:  Eur J Hum Genet       Date:  2009-12-02       Impact factor: 4.246

4.  Rapid aneuploidy detection or karyotyping? Ethical reflection.

Authors:  Antina de Jong; Wybo J Dondorp; Daniëlle R M Timmermans; Jan M M van Lith; Guido M W R de Wert
Journal:  Eur J Hum Genet       Date:  2011-06-01       Impact factor: 4.246

Review 5.  An Older Woman in Early Pregnancy: What Antenatal Screening is Appropriate?

Authors:  S Sulaiha Aznal
Journal:  Malays Fam Physician       Date:  2008-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.